Giovanni de Gaetano

MD (Rome, Catholic University), PhD (Leuven University, Belgium), MD honoris causa (Debrecen University, Hungary and Bialystok University, Poland). Knight of merit of the Italian Republic

Appointed Director of the Laboratory of Cardiovascular Clinical Pharmacology at Mario Negri Institute, Milan, while being still a post-doc fellow. At the end of the Eighties, he moved to Central Southern Italy, where he was a co-founder and first Director of a new research institute, the Mario Negri Sud. He was then appointed in 2002 Director of the Research Laboratories at the “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences of the Catholic University, Campobasso. Since 2013, he was Head of the Department of Epidemiology and Prevention, IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli (Isernia) and is presently President of the Board of Neuromed.

Author of more than 600 peer-reviewed publications (Pubmed), with a H-index of 92 and more than 46,000 citations; his major scientific contributions are related to low-dose aspirin as an antiplatelet and antithrombotic drug and to the characterization of moderate wine and alcohol consumption (in the context of a Mediterranean Diet) as associated with reduced cardiovascular outcomes and all-cause mortality.

His major current scientific interests include epidemiology of common risk factors for cardiovascular disease, cancer and neuro-degenerative disorders (the Moli-sani Study on over 24,000 adult participants from the general population, www.moli-sani.org), epidemiology of food, nutrition and health, clinical pharmacology of aspirin and natural polyphenols. He is also an expert of science communication. Lately, he was appointed as the first Editor in Chief of the new scientific journal “Bleeding, Thrombosis and Vascular Biology”, BTVB.